.png){kind=small}
Physician-reviewed TRT monitoring guide
Already on testosterone therapy? Your treatment-level goal is a different question from the level used to diagnose low testosterone before treatment.
Medically reviewed by Timothy Mackey, D.O., Medical Director of NovaGenix.
What should my testosterone level be while on TRT?
For men being treated for testosterone deficiency, the American Urological Association recommends adjusting therapy to achieve total testosterone in the middle tertile of the normal reference range. The AUA identifies approximately 450–600 ng/dL as a practical physiologic treatment range for most laboratories.
That does not mean every man on TRT must land on exactly the same number. The result should be interpreted with symptom response, free testosterone when appropriate, SHBG, treatment method, dose, safety monitoring and—especially for injections—the timing of the blood draw.
Bottom line: a reasonable evidence-based starting point is about 450–600 ng/dL, but ultimately the number is just that—a number. It has to be cross-referenced with symptom resolution, treatment response and safety monitoring.
Every patient is unique, and there is no single testosterone number that can be applied to every man on TRT. A value in the upper portion of a laboratory's physiologic reference range is not necessarily a bad result simply because it is above 600 ng/dL. If the patient has meaningful symptom resolution, is not experiencing treatment-related adverse effects, and monitoring does not show concerning changes such as excessive increases in red blood cell measures or hematocrit, a clinician may determine that a higher individual level is acceptable in context.
The goal is therefore not to treat the laboratory number by itself. It is to use the lowest effective testosterone exposure that produces clinical benefit while maintaining appropriate safety markers. Hematocrit is particularly important: a rising value may require reassessment of dose, formulation, contributing factors and the overall treatment plan even when the patient feels well.
TRT target levels are not the same as the diagnostic cutoff
Before treatment, the question is whether a man has testosterone deficiency. The AUA uses total testosterone below 300 ng/dL as a reasonable cutoff supporting diagnosis when compatible symptoms or signs and repeat morning testing are also present.
Once a man is receiving TRT, the objective is different: restore testosterone to a physiologic treatment range while improving relevant symptoms and avoiding unnecessary exposure or adverse effects. A diagnostic cutoff of 300 ng/dL is not the treatment target.
| Question | Number often used | What it means |
|---|---|---|
| Could I have testosterone deficiency? | Below 300 ng/dL | AUA diagnostic cutoff; symptoms/signs and appropriate repeat testing still matter. |
| What level should TRT aim for? | 450–600 ng/dL | AUA practical target corresponding to the middle tertile of the normal physiologic range. |
| What is a normal untreated range? | Varies by laboratory | A reference interval is not automatically a TRT treatment target. |
For untreated levels, see Normal Testosterone Levels in Men: Average Levels by Age.
Why blood-draw timing can change the answer
A testosterone result only makes sense when the clinician knows when the medication was given. Testosterone cypionate and enanthate concentrations change across the dosing interval. A result obtained relatively soon after an injection can differ substantially from one obtained later in the interval.
The AUA recommends waiting until a patient on short-acting intramuscular or subcutaneous testosterone cypionate or enanthate has completed at least three to four dosing cycles before assessing the on-treatment level. Consistent timing makes serial results easier to compare.
A 550 ng/dL result without the date and time of the last testosterone dose is incomplete information. Tell the clinician when the injection, cream, gel or other formulation was last administered.
Should men on TRT aim for 800, 900 or 1,000 ng/dL?
Not simply because those numbers are higher. Major guidelines do not recommend pushing every patient toward the top of a laboratory reference interval. The AUA recommends using the minimum dose necessary to reach the normal physiologic treatment range and improve symptoms.
A higher total testosterone value does not automatically mean better energy, libido, body composition or health. Increasing testosterone exposure can also affect hematocrit, estradiol, blood pressure and other safety considerations. The goal is clinical improvement with appropriate physiologic exposure—not the highest laboratory number.
What if I feel better above 600 ng/dL?
One laboratory value should not be interpreted in isolation. Assays and reference intervals differ, and treatment method and blood-draw timing influence the result. An appropriately treated patient may have a measured level outside 450–600 ng/dL at a particular point in the dosing cycle.
An individual result outside the AUA's practical range is not the same as establishing a new universal target. Dose decisions should consider the complete clinical picture.
Total testosterone vs. free testosterone on TRT
Total testosterone is the primary number used in most treatment guidelines, but SHBG influences how much circulating testosterone is bound. When SHBG is unusually high or low, total testosterone may not tell the whole story.
In selected patients, free testosterone can add useful context. The testing method matters, and free-testosterone results from different assays should not be treated as interchangeable.
What else should be monitored besides testosterone?
TRT follow-up is more than checking total testosterone. Depending on age, history, symptoms and treatment plan, monitoring may include:
- Symptoms and treatment response
- Complete blood count and hematocrit
- Blood pressure
- Estradiol when clinically indicated
- PSA and prostate monitoring when appropriate
- Total and free testosterone when appropriate
- Medication dose, frequency and timing
- Sleep apnea and cardiovascular risk factors
- Fertility goals
For estradiol specifically, see Estradiol on TRT: What Levels Should Men Aim For?.
How often should testosterone levels be checked on TRT?
The AUA recommends an initial follow-up testosterone measurement after enough time has passed to determine whether treatment has achieved therapeutic levels. Once therapeutic levels are established, testosterone should generally be measured every 6–12 months, with additional testing when clinically appropriate or after treatment changes.
The Endocrine Society also emphasizes structured follow-up after TRT begins to assess treatment response, adverse effects and adherence.
What if testosterone reaches the target but I still do not feel better?
If testosterone has normalized but symptoms attributed to low testosterone do not improve, simply escalating the dose may not solve the problem. The AUA advises reconsidering whether testosterone deficiency is responsible for the symptoms and discussing cessation when normalized levels fail to produce meaningful symptom improvement after an appropriate treatment period.
Fatigue, low libido, erectile dysfunction and poor concentration can also occur with sleep disorders, thyroid disease, depression, medication effects, cardiovascular disease and other conditions.
Does the type of TRT change how the level should be interpreted?
Yes. Injectable testosterone, topical gels and creams, nasal formulations, oral testosterone undecanoate and long-acting preparations have different pharmacokinetics. Appropriate bloodwork timing depends on the formulation.
For the separate question of dose, see What Is a Normal Dose of Testosterone for Patients on TRT?.
Frequently asked questions
Is 500 ng/dL a good testosterone level on TRT?
It falls within the AUA's practical 450–600 ng/dL physiologic treatment range. Whether it represents appropriate treatment for an individual still depends on symptoms, blood-draw timing, formulation, free testosterone or SHBG when relevant, and safety monitoring.
Is 700 ng/dL too high on TRT?
Not necessarily. One value does not establish excessive treatment. The clinician should consider the laboratory range, timing relative to the dose, symptoms and safety markers.
Should I keep my testosterone at 1,000 ng/dL?
Major U.S. guidelines do not recommend 1,000 ng/dL as a universal TRT target. The AUA recommends the middle tertile of the normal physiologic range, approximately 450–600 ng/dL for most laboratories.
What testosterone level is too low while on TRT?
A persistently subtherapeutic result may prompt review of dose, adherence, administration technique, timing and formulation, but it should be interpreted by the prescribing clinician rather than against a single internet cutoff.
When should I test after a testosterone injection?
Testing strategy depends on formulation and schedule. For short-acting cypionate or enanthate, the AUA recommends assessing levels only after several dosing cycles have established a stable regimen. Keep blood-draw timing consistent and document the last injection.
TRT monitoring at NovaGenix
NovaGenix uses physician-led follow-up to interpret testosterone results in context rather than treating one laboratory number in isolation. Treatment decisions consider symptoms, laboratory trends, medication timing, safety markers and patient goals.
Learn more about testosterone replacement therapy at NovaGenix or request a consultation.
Medical references
- American Urological Association: Testosterone Deficiency Guideline
- Endocrine Society: Testosterone Therapy in Men With Hypogonadism
- Endocrine Society 2026 Statement on Testosterone Replacement Therapy
Educational information only. This page does not diagnose a condition or replace individualized medical advice. Prescription treatment requires evaluation and ongoing monitoring by a licensed clinician.
